TickerFacts.

PepGen Inc. (PEPG): Net Income

Annual figures by period end, from SEC filings.

-$89.66M
Year ended 2025-12-31
-$71.94M
Trailing 12 months to 2026-06-30
2021-12-31: -$27.28M2022-12-31: -$69.10M2023-12-31: -$78.63M2024-12-31: -$89.98M2025-12-31: -$89.66M-$89.66M
2021-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$89.66Mn/m2026-03-04, From 2025-01-01
2024-12-31-$89.98Mn/m2026-03-04, From 2024-01-01
2023-12-31-$78.63Mn/m2025-02-24, From 2023-01-01
2022-12-31-$69.10Mn/m2024-03-29, From 2022-01-01
2021-12-31-$27.28Mn/a2023-03-23, From 2021-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
PepGen Inc. (PEPG)2025-12-31-$89.66Mn/m
Gossamer Bio, Inc. (GOSS)2025-12-31-$170.37Mn/m
Eledon Pharmaceuticals, Inc. (ELDN)2025-12-31-$45.62Mn/m
Corbus Pharmaceuticals Holdings, Inc. (CRBP)2025-12-31-$78.54Mn/m
Climb Bio, Inc. (CLYM)2025-12-31-$59.85Mn/m
Gyre Therapeutics, Inc. (GYRE)2025-12-31$9.88M-44.8%
Benitec Biopharma Inc. (BNTC)2026-06-30-$45.55Mn/m
Apimeds Pharmaceuticals US, Inc. (APUS)2025-12-31-$6.00Mn/m
Alto Neuroscience, Inc. (ANRO)2025-12-31-$63.24Mn/m

Compare PEPG, GOSS, ELDN, CRBP side by side · Screen every company in Pharmaceutical Preparations ↗